Estimation of absolute risk for prostate cancer using genetic markers and family history

Multiple DNA sequence variants in the form of single‐nucleotide polymorphisms (SNPs) have been found to be reproducibly associated with prostate cancer (PCa) risk.

[1]  B. Trock,et al.  Individual and cumulative effect of prostate cancer risk‐associated variants on clinicopathologic variables in 5,895 prostate cancer patients , 2009, The Prostate.

[2]  J. Carpten,et al.  Association of reported prostate cancer risk alleles with PSA levels among men without a diagnosis of prostate cancer , 2009, The Prostate.

[3]  Cornelia M van Duijn,et al.  Genome-based prediction of common diseases: advances and prospects. , 2008, Human molecular genetics.

[4]  M. Thun,et al.  Variation in KLK genes, prostate-specific antigen and risk of prostate cancer , 2008, Nature Genetics.

[5]  J. Carpten,et al.  Cumulative effect of five genetic variants on prostate cancer risk in multiple study populations , 2008, The Prostate.

[6]  J. Carpten,et al.  Evidence for two independent prostate cancer risk–associated loci in the HNF1B gene at 17q12 , 2008, Nature Genetics.

[7]  Peter M Visscher,et al.  Prediction of individual genetic risk of complex disease. , 2008, Current opinion in genetics & development.

[8]  Kevin M. Bradley,et al.  Common sequence variants on 2p15 and Xp11.22 confer susceptibility to prostate cancer , 2008, Nature Genetics.

[9]  Ali Amin Al Olama,et al.  Multiple newly identified loci associated with prostate cancer susceptibility , 2008, Nature Genetics.

[10]  W. Willett,et al.  Multiple loci identified in a genome-wide association study of prostate cancer , 2008, Nature Genetics.

[11]  Pär Stattin,et al.  Cumulative association of five genetic variants with prostate cancer. , 2008, The New England journal of medicine.

[12]  J. Carpten,et al.  Two genome-wide association studies of aggressive prostate cancer implicate putative prostate tumor suppressor gene DAB2IP. , 2007, Journal of the National Cancer Institute.

[13]  Olufunmilayo I. Olopade,et al.  Breast cancer risk associated with BRCA1 and BRCA2 in diverse populations , 2007, Nature Reviews Cancer.

[14]  D. Gudbjartsson,et al.  Two variants on chromosome 17 confer prostate cancer risk, and the one in TCF2 protects against type 2 diabetes , 2007, Nature Genetics.

[15]  P. Donnelly,et al.  A new multipoint method for genome-wide association studies by imputation of genotypes , 2007, Nature Genetics.

[16]  P. Fearnhead,et al.  Genome-wide association study of prostate cancer identifies a second risk locus at 8q24 , 2007, Nature Genetics.

[17]  D. Gudbjartsson,et al.  Genome-wide association study identifies a second prostate cancer susceptibility variant at 8q24 , 2007, Nature Genetics.

[18]  Jinbo Chen,et al.  Projecting absolute invasive breast cancer risk in white women with a model that includes mammographic density. , 2006, Journal of the National Cancer Institute.

[19]  Ewout W Steyerberg,et al.  Predictive testing for complex diseases using multiple genes: Fact or fiction? , 2006, Genetics in Medicine.

[20]  A. Gylfason,et al.  A common variant associated with prostate cancer in European and African populations , 2006, Nature Genetics.

[21]  A. Chokkalingam,et al.  Prostate cancer epidemiology. , 2006, Frontiers in bioscience : a journal and virtual library.

[22]  Ruth Etzioni,et al.  Lifetime implications and cost-effectiveness of using finasteride to prevent prostate cancer. , 2005, The American journal of medicine.

[23]  M. Pepe,et al.  Limitations of the odds ratio in gauging the performance of a diagnostic, prognostic, or screening marker. , 2004, American journal of epidemiology.

[24]  Michael M Lieber,et al.  The influence of finasteride on the development of prostate cancer. , 2003, The New England journal of medicine.

[25]  N. Wald,et al.  When can a risk factor be used as a worthwhile screening test? , 1999, BMJ.

[26]  W. Dupont.  Converting relative risks to absolute risks: a graphical approach. , 1986, Statistics in medicine.

[27]  Jin Woo Kim,et al.  Sequence variants at 22q13 are associated with prostate cancer risk. , 2009, Cancer research.